| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.81M | 49.57M | 40.63M | 90.26M | 70.40M | 39.52M |
| Gross Profit | 11.48M | 18.02M | 5.46M | 33.93M | 22.11M | 13.64M |
| EBITDA | 148.10K | -333.00K | -12.61M | 14.22M | 7.82M | 3.54M |
| Net Income | -6.79M | -7.98M | -21.93M | 8.23M | 2.63M | -3.16M |
Balance Sheet | ||||||
| Total Assets | 35.43M | 41.26M | 49.11M | 64.25M | 64.43M | 24.85M |
| Cash, Cash Equivalents and Short-Term Investments | 3.34M | 2.71M | 5.32M | 11.84M | 5.96M | 2.95M |
| Total Debt | 4.14M | 4.66M | 5.75M | 8.38M | 9.14M | 6.79M |
| Total Liabilities | 17.03M | 21.44M | 21.45M | 29.11M | 38.17M | 22.01M |
| Stockholders Equity | 18.40M | 19.82M | 27.65M | 35.13M | 26.26M | 2.84M |
Cash Flow | ||||||
| Free Cash Flow | 397.88K | -772.00K | -16.86M | 8.77M | -628.00K | 3.13M |
| Operating Cash Flow | 869.89K | 1.49M | -11.94M | 15.70M | 5.48M | 6.76M |
| Investing Cash Flow | -1.36M | -2.24M | -7.14M | -8.23M | -10.06M | -3.63M |
| Financing Cash Flow | -433.68K | -1.84M | 12.64M | -1.60M | 7.59M | -1.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £81.40M | 54.18 | 2.93% | ― | -3.95% | 16.87% | |
69 Neutral | £49.52M | -76.52 | -0.75% | 7.26% | 8.00% | -253.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | £28.89M | -10.45 | -7.07% | ― | 1.73% | -68.87% | |
50 Neutral | £13.27M | -2.98 | -32.23% | ― | -7.72% | 54.13% | |
48 Neutral | £9.13M | -2.95 | -34.87% | ― | -9.19% | 4.69% | |
43 Neutral | £1.31M | -1.88 | -110.31% | ― | -38.77% | -1.67% |